These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31063768)

  • 1. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
    Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Jul; 855():103-111. PubMed ID: 31063768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).
    Luethi D; Trachsel D; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):141-148. PubMed ID: 28720478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2019; 10():1423. PubMed ID: 31849671
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2021; 12():794254. PubMed ID: 35222010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bulky
    Soares BA; Yempala T; Martínez-Afani D; Acevedo-Fuentes W; Brea J; Loza MI; Cimadevila M; Cassels BK
    ACS Chem Neurosci; 2024 Feb; 15(3):608-616. PubMed ID: 38241462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
    Hansen M; Jacobsen SE; Plunkett S; Liebscher GE; McCorvy JD; Bräuner-Osborne H; Kristensen JL
    Bioorg Med Chem; 2015 Jul; 23(14):3933-7. PubMed ID: 25583099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.
    Luethi D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2018 Jan; 819():242-247. PubMed ID: 29225192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
    Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
    Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of methylphenidate-based designer drugs.
    Luethi D; Kaeser PJ; Brandt SD; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):133-140. PubMed ID: 28823611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profiles of compounds in preworkout supplements ("boosters").
    Rickli A; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Sep; 859():172515. PubMed ID: 31265842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines.
    Halberstadt AL; Luethi D; Hoener MC; Trachsel D; Brandt SD; Liechti ME
    Psychopharmacology (Berl); 2023 Jan; 240(1):115-126. PubMed ID: 36477925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
    Nichols DE; Frescas S; Marona-Lewicka D; Huang X; Roth BL; Gudelsky GA; Nash JF
    J Med Chem; 1994 Dec; 37(25):4346-51. PubMed ID: 7996545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes.
    McKenna DJ; Repke DB; Lo L; Peroutka SJ
    Neuropharmacology; 1990 Mar; 29(3):193-8. PubMed ID: 2139186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.
    Pottie E; Cannaert A; Stove CP
    Arch Toxicol; 2020 Oct; 94(10):3449-3460. PubMed ID: 32627074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.